Concepedia
Publication | Open Access
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
107
Citations
28
References
2020
Year
Page 1